The largest database of trusted experimental protocols

18 protocols using cytoflex lx cytometer

1

Evaluating STING Agonist Efficacy in Human PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy human whole bloods were purchased from Research Blood Components LLC. All donors filled out their standard medical questionnaire and agreed to their donor informed consent form before blood donation. PBMCs were isolated from whole blood using SepMate tubes (STEMCELL Technologies). Cells were plated in round-bottom 96-well plates at 200,000 cells per well in RPMI supplemented with 10% fetal bovine serum. ExoSTING or free CDNs were added to the wells in a final volume of 200 µL and incubated overnight at 37 °C and 5% CO2. The next day, the supernatant was harvested and analyzed for human IFN-β using an AlphaLISA kit according to the manufacturer’s protocol (Perkin Elmer). The cells were pelleted, washed, and stained for flow cytometry. Expression of the activation marker CD86 on CD11c+ dendritic cells and CD14+ monocytes were assessed. Flow cytometry analysis was completed either on a SA3800 Spectral Cell Analyzer (Sony) or Beckman Coulter CytoFLEX LX cytometer. EC50 values were analyzed by using GraphPad Prism 8. Antibody information is listed in Supplementary Table 2.
+ Open protocol
+ Expand
2

Flow Cytometry and NanoString Data Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed using a BD LSRII flow cytometer equipped with BD FACSDiva software or BD FACSCaliber or Beckman Coulter’s Cytoflex LX cytometer. All flow data were analyzed using FlowJo version 10.0 software. NanoString data analysis was performed by the UK genomic core laboratory using the SAS program. Statistical analysis for all other studies was performed using GraphPad Prism 7.0 software and comparing means by a simple Student t test or by ANOVA with Tukey multiple comparison correction. The Mantel–Cox test was used for survival curves. A p value <0.05 was considered statistically significant.
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
1–2 × 106 cells were placed in 200 uL of PBS1X with 2% FBS on ice and antibodies were added, mixed, and incubated for 30 min. Then, cells were washed with PBS1X and centrifuged at 800×g for 5 min. Finally, samples were acquired in a CytoFLEX LX cytometer (Beckman Coulter). Analysis was performed using CytExpert software. The following anti human antibodies were used: AF488 anti-GRP78 (Clone: C38), AF700 anti-CD45 (Clone: HI30), APC anti-CD34 (Clone: 561), PE/Cy7 anti-CD38 (Clone: HB-7), PerCP/Cy5.5 anti-CD19 (Clone: HIN19), PE/Dazzle anti-CD10 (Clone: HI10a), Brilliant Violet 421 anti-CD184 (clone: 12G5) and the Zombie Aqua™ Fixable Viability Kit was used according to the manufacture (Biolegend).
+ Open protocol
+ Expand
4

Microvascular Isolation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primary microvessels were cultured in TGM2D medium for 3 or 7 days before flow cytometric analysis. For flow cytometry, the primary microvessels were dissociated into single cells by accutase (Sigma, Cat#A6964). The staining procedure was performed on ice, including the following: blocking in 3% normal donkey serum for 15 min, incubation in primary antibodies (CD31 from Novus, Cat#AF3628, NG2 from Proteintech, Cat#55027-1-AP, CD45 from Proteintech, Cat#20103-1-AP), secondary antibodies (Invitrogen, Molecular probes, Cat#A10040, A-21202, A-21447). The cells were suspended in the sorting buffer containing 1% BSA and 1 mM EDTA in PBS, went through a single-cell strainer before analysis on a Beckman CytoFLEX LX cytometer.
+ Open protocol
+ Expand
5

Liver Immune Cell Isolation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh liver tissues were dissociated using a gentleMACS Dissociator (Miltenyi Biotec) and mouse Liver Dissociation Kit (Miltenyi Biotec, Bergisch Gladbach Germany). After separation and purification from the cell suspension by Percoll gradient centrifugation, liver immune cells were stained with antibodies and then subjected to a CytoFLEX LX cytometer (Beckman Coulter, CA, USA). The antibodies used in flow cytometry are listed in Table S1.
+ Open protocol
+ Expand
6

Cytokine and Exhaustion Marker Analysis of CAR-T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cytokines and exhaustion markers analysis, CAR-T cells were stimulated with irradiated 8505c-TSHR cells for 24 h. The BD Cytometric Bead Array (CBA) kit were used to quantify the secretion level of IL-2, TNFα and IFN-γ of the supernatant of CAR-T cells following manufacturer’s instruction. For intracellular cytokines staining, the Golgi plug protein transport inhibitor Brefeldin A (eBioscience, San Diego, United States) was added into the cultured medium 4 h before detection. T cells were then fixed and permeabilized with Fixation and Permeabilization kit (BD Biosciences, San Jose, United States) according to manufacturer’s instruction. The following antibodies were used: FITC mouse anti-human TSHR (Santa Cruz Biotechnology, Santa Cruz, United States), Human IL-2 Flex Set (BD Biosciences), Human TNF Flex Set (BD Biosciences), Human IFN-γ Flex Set (BD Biosciences), BV421 rat anti-human IL-2 (BD Biosciences), PE-Cy7 mouse anti-human TNFα (BD Biosciences), PE-Cy7 anti-human CD279 (PD-1) (eBioscience), eFluor 450 anti-human CD223 (LAG-3) (eBioscience). Flow cytometry was performed on a CytoFLEX LX cytometer (Beckman Coulter, Brea, United States). A moflo Astrios EQ cell sorter (Beckman Coulter) was used for cell sorting. Data were analyzed with FlowJo software (FlowJo LLC, Ashland, United States).
+ Open protocol
+ Expand
7

Flow Cytometry Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were analyzed on a BD LSRFortessa X-20 Cell Analyzer, BD LSRFortessa Cell Analyzer, or Beckman Coulter CytoFLEX LX Cytometer. For each experiment, 10,000 to 20,000 cells were analyzed. Data were analyzed with FlowJo software.
+ Open protocol
+ Expand
8

T cell activation and proliferation analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stimulation of CD3-enriched T cells as well as DNA-sensor inhibition treatment with RU.521 and ODN A151 were performed as described above. For the staining, 200,000 cells were harvested, washed, and stained with Live/Dead Fixable Blue (Invitrogen) for discrimination of dead cells. Then, cells were stained as described previously.43 (link) Briefly, the cells were fixed and permeabilized using the Intracellular Fixation & Permeabilization Buffer Set (Thermo Fisher Scientific, 88-8824). A mastermix containing 7AAD and KI67 Alexa Fluor 647 (BioLegend) was added to the cells for 30 min at 4°C in the dark. After washing, cells were resuspended in PBS and run on the Cytoflex LX cytometer (Beckman Coulter Genomics). The 7AAD dye stains DNA and indicates individual cell genomic DNA content to allow for differentiation of cells in resting (G0) and G1 phase versus cells in S and G2 phase. Ki-67 is an activation and proliferation marker that indicates cells outside resting phase (G0).
+ Open protocol
+ Expand
9

Immunophenotyping of Cell Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were collected in 96-well V bottom plates and pelleted at 300g for 5 min. Supernatant was aspirated, and cells were washed in 200 μl of PBS per well (Thermo Fisher Scientific, 10010049). Cells were incubated for 15 min at room temperature in the dark in 50 μl of PBS with Fc Block (1:100 dilution, BD, 564220) and Zombie ultraviolet dye (1:500 dilution, BioLegend, 423108). Next, 50 μl of antibody cocktail made up at 2× working concentration in HF buffer (HBSS, Thermo Fisher Scientific, 14175103, supplemented with 2% FBS, Thermo Fisher Scientific, 12483020) was mixed 1:1 with the cell suspension. Cells were stained for 30 min on ice protected from light and washed twice with 200 μl of HF buffer per well. Samples were analyzed on a CytoFLEX LX cytometer (Beckman), compensation was performed in CytExpert v2.3, and data were gated and plotted in FlowJo v9. Antibodies used are listed in workbook S1.
+ Open protocol
+ Expand
10

Comprehensive Immune Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using flow cytometry, blood samples were processed with an extensive panel of human-specific monoclonal antibodies. These antibodies included anti-CD3 PerCp, anti-CD4 BV421, anti-CD8 BV605, anti-CD19 FITC, and anti-CD45 AF700, along with other antibodies targeting immune checkpoints and pertinent markers, such as anti-PD-1 APC, anti-PD-L1 PE, anti-CTLA-4 PE, anti-CD86 APC, anti-CD200 PE, and anti-CD200R APC. All of these antibodies were sourced from BioLegend (San Diego, CA, USA). For accurate gating during cytometric analysis, FMO controls were incorporated specifically for the immune checkpoints’ antibodies.
After the antibody incubation stage, red blood cells were lysed using a specific buffer from BD (Franklin Lakes, NJ, USA). This lysing solution was prepared following the manufacturer’s protocol to ensure optimal cell lysis. The post-lysis cell suspension was then washed and analyzed on the CytoFLEX LX cytometer (Beckman Coulter, Indianapolis, IN, USA). For subsequent data interpretation, Kaluza Analysis software, version 2.1, also from Beckman Coulter, was used. The CytoFLEX LX system’s consistent quality was upheld using CytoFLEX Ready to Use Daily QC Fluorospheres reagents (Beckman Coulter, Indianapolis, IN, USA). Figure 1 and Figure 2 present the results of the sample analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!